Similarly, a higher proportion of memory activated CD4 T cells was associated with improved RFS, possibly from facilitation of anti-tumor response from cytotoxic T cells, production of effector cytokines such as IFNγ and tumor necrosis factor-α (TNFα), and induction of B cell driven humoral responses against tumor antigens (43). The gene discussed is CD4; the disease is neoplasm.